3654 results for «600»
3654 results
AICT-AsiaPCR 2025 Awards ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.
AICT-AsiaPCR 2025 Closing ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive Course, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.
AICT-AsiaPCR 2025 Opening ceremony
10 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.
Complex coronary interventions - Current day challenges and solutions
11 Oct 2025 – From AICT-AsiaPCR 2025
Addressing current challenges in complex coronary interventions, this session covers management strategies for CHIP patients, advanced techniques for highly calcified lesions, and principles for mechanical circulatory support application in high-risk PCI scenarios. It offers practical insights and case-based discussions to optimize safety and efficacy in contemporary...
Very resistant stenosis in stent failure - LIVE Case
11 Oct 2025 – From AICT-AsiaPCR 2025
A 57-year-old male with a history of multivessel PCI—LAD and LCX stents in 2012 and RCA CTO stent in 2022—presented with normal LV function. He was asymptomatic but had a positive nuclear stress test. Control angiography showed suboptimal left coronary arteries with negative iFR. However, there...
Coronary complications and rescue cases
11 Oct 2025 – From AICT-AsiaPCR 2025
This compelling session addresses complex coronary complications and rescue cases encountered in the cath lab. Through a series of challenging case studies, it highlights critical scenarios such as silent coronary artery threats, procedural nightmares, coronary perforations, and innovative rescue strategies that transform high-risk situations into successful...
CTO PCI in images and case examples: what is new in 2026?
07 Jul 2026
Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)